These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 20719535
1. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT). Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Japan Alteplase Clinical Trial (J-ACT) Group. J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535 [Abstract] [Full Text] [Related]
2. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D. Cerebrovasc Dis; 2013 Nov; 35(1):45-52. PubMed ID: 23428996 [Abstract] [Full Text] [Related]
4. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis. Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD. Cerebrovasc Dis; 2007 Nov; 24(1):56-65. PubMed ID: 17519545 [Abstract] [Full Text] [Related]
7. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH. J Stroke Cerebrovasc Dis; 2011 Nov; 20(2):124-30. PubMed ID: 20598579 [Abstract] [Full Text] [Related]
8. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K. Cerebrovasc Dis; 2012 Nov; 34(2):140-6. PubMed ID: 22854333 [Abstract] [Full Text] [Related]
9. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome. Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA. Cerebrovasc Dis; 2012 Nov; 33(2):135-40. PubMed ID: 22179586 [Abstract] [Full Text] [Related]
12. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era. Endo K, Koga M, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators. J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823 [Abstract] [Full Text] [Related]
13. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N, SITS investigators. Neurology; 2012 Mar 20; 78(12):880-7. PubMed ID: 22402853 [Abstract] [Full Text] [Related]
17. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI. J Stroke Cerebrovasc Dis; 2008 Sep 20; 17(5):266-72. PubMed ID: 18755405 [Abstract] [Full Text] [Related]
18. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Shobha N, Buchan AM, Hill MD, Canadian Alteplase for Stroke Effectiveness Study (CASES). Cerebrovasc Dis; 2011 Sep 20; 31(3):223-8. PubMed ID: 21178345 [Abstract] [Full Text] [Related]
19. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M. Cerebrovasc Dis; 2008 Sep 20; 25(1-2):129-35. PubMed ID: 18073466 [Abstract] [Full Text] [Related]